cannabinoid receptor agonists

June 19, 2024

In vitro activation of the CB1 receptor by the semi‐synthetic cannabinoids hexahydrocannabinol (HHC), hexahydrocannabinol acetate (HHC‐O) and hexahydrocannabiphorol (HHC‐P)

Abstract Semi‐synthetic cannabinoids (SSCs) including hexahydrocannabinol (HHC) are emerging on the drug market and sold openly as purportedly legal replacements…

July 30, 2021

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist

Abstract The endocannabinoid system has attracted attention as a pharmacological target for several pathological conditions. Cannabinoid (CB2)-selective agonists have been…

March 2, 2016

Rising Threat; Bonsai

Abstract Objectives: In recent years, and especially in the past few months, the number of synthetic cannabinoid (bonsai) users has…

March 13, 2014

Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain

Abstract A lack of efficacy of some analgesic drugs has been previously described in rats with neuropathic spinal cord injury…